PlatformTeamCareersPressContact
Press

The latest from Terray.

Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies

Press Release October 28, 2024

Terray Therapeutics Closes Oversubscribed $120M Series B to Advance Its Generative AI Pipeline of Small Molecule Therapeutics to the Clinic

Press Release October 17, 2024

How A.I. Is Revolutionizing Drug Development

The New York Times June 17, 2024

Terray Therapeutics Announces Multi-Target Collaboration with Bristol Myers Squibb

Press Release December 14, 2023

Terray Therapeutics Announces Investment from NVIDIA to Enable Generative AI Design for Drug Discovery

Press Release November 9, 2023

Terray Therapeutics Strengthens Leadership with Appointment of Sudha Parasuraman, MD to its Board of Directors

Press Release May 16, 2023

Terray Therapeutics Appoints John Maraganore, Ph.D., as Strategic Advisor

Press Release December 13, 2022

Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director

Press Release November 30, 2022

Terray Therapeutics and Calico Enter into a Multi-Target Collaboration to Discover Small Molecule Therapeutics for Age-Related Diseases

Press Release October 12, 2022

Terray Therapeutics Expands Scientific Advisory Board to Advance AI-Driven Small Molecule Drug Discovery

Press Release July 12, 2022

Terray Therapeutics Expands Leadership Team with Fez Ujjainwalla, PhD as Head of Business

Press Release March 1, 2022

Founded and Funded – Terray Therapeutics Building an Intersection of Innovation Company

Madrona Venture Group February 27, 2022

Terray Therapeutics Launches with $60M to Deliver Premium Chemical Data at Unrivaled Scale, Unlocking the Potential of AI-Driven Small Molecule Drug Discovery

Press Release February 15, 2022
LinkedIn
PrivacyTerms
© 2024 Terray Therapeutics, Inc.